You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

retifanlimab

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Retifanlimab
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Retifanlimab
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Glioma, Glioblastoma Trial in United States (drug, radiation, procedure)

Recruiting
  • Glioma
  • Glioblastoma
  • Phoenix, Arizona
  • +3 more
Oct 13, 2022

Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)

Recruiting
  • Breast Cancer
  • +3 more
  • SV-BR-1-GM
  • +3 more
  • Newport Beach, California
  • +9 more
Dec 8, 2022

Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)

Recruiting
  • Merkel Cell Carcinoma
  • Retifanlimab
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Jan 4, 2023

Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon

Not yet recruiting
  • Breast Cancer
  • +4 more
  • SV-BR-1-GM
  • +4 more
  • Port Jefferson Station, New York
    New York Cancers & Blood Specialists
Oct 2, 2023

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

DLBCL, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Retifanlimab
  • All-trans retinoic acid
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

Withdrawn
  • Advanced Neuroendocrine Neoplasm
  • Carcinoid Syndrome
  • Retifanlimab
  • Telotristat Ethyl
  • (no location specified)
Sep 23, 2021

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Chuo Ku, Kashiwa (Retifanlimab, INCB001158, Retifanlimab + INCB001158)

Completed
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Retifanlimab
  • +2 more
  • Chuo Ku, Japan
  • +1 more
Feb 24, 2022

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Neoantigen Vaccine with Poly-ICLC adjuvant
  • Retifanlimab
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

Recruiting
  • Gastric Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
  • +7 more
Jan 31, 2022

Advanced Malignancies Trial in Worldwide (Pemigatinib, Retifanlimab, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Santa Monica, California
  • +6 more
Apr 6, 2022

Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

Recruiting
  • Urothelial Carcinoma
  • retifanlimab
  • +3 more
  • Iowa City, Iowa
  • +11 more
Dec 1, 2022

Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

Recruiting
  • Head and Neck Cancer
  • Retifanlimab
  • +3 more
  • Scottsdale, Arizona
  • +87 more
Dec 12, 2022

Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

Recruiting
  • Endometrial Cancer
  • retifanlimab
  • +4 more
  • Anchorage, Alaska
  • +78 more
Jul 25, 2022

Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • Los Angeles, California
  • +31 more
Jul 20, 2022

Squamous Cell Carcinoma of the Anal Canal Trial in Worldwide (carboplatin, paclitaxel, retifanlimab)

Recruiting
  • Squamous Cell Carcinoma of the Anal Canal
  • Tucson, Arizona
  • +85 more
Jun 13, 2022

NSCLC Trial (Retifanlimab, Placebo, Pemetrexed)

Withdrawn
  • Non-small Cell Lung Cancer
  • Retifanlimab
  • +7 more
  • (no location specified)
Jun 5, 2020

Advanced and/or Metastatic Solid Tumors, Stage IIIB Not Amenable to Curative Therapy to Stage IV NSCLC, Advanced/Metastatic

Withdrawn
  • Advanced and/or Metastatic Solid Tumors
  • +2 more
  • Retifanlimab
  • +5 more
  • (no location specified)
Apr 21, 2020

Squamous Cell Carcinoma of Anal Canal Trial in Worldwide (Retifanlimab)

Completed
Has Results
  • Squamous Cell Carcinoma of Anal Canal
  • Retifanlimab
  • Duarte, California
  • +46 more
Jan 11, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (retifanlimab)

Active, not recruiting
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • retifanlimab
  • Scottsdale, Arizona
  • +79 more
Nov 9, 2022